Timeline
Véronique Mayau
Technician
01 Jan 2023
publication
Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.
Read more07 Mar 2022
11 Jan 2022
news
New publication – The Sec61 translocon is a therapeutic vulnerability in multiple myeloma
Read more24 Dec 2021
publication
De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis.
Read more24 Sep 2020
publication